Serum indicators for the diagnosis of pneumocystis pneumonia.
about
HIV-Associated Pneumocystis PneumoniaCharacterization of a distinct host response profile to Pneumocystis murina asci during clearance of pneumocystis pneumoniaPneumocystis jirovecii Pneumonia in Rheumatoid Arthritis Patients: Risks and Prophylaxis RecommendationsPneumocystis Pneumonia in Human Immunodeficiency Virus-infected Adults and Adolescents: Current Concepts and Future DirectionsHost Factors and Biomarkers Associated with Poor Outcomes in Adults with Invasive Pneumococcal DiseaseTherapeutic effect of direct hemoperfusion with a polymyxin B-immobilized fiber column in the treatment of HIV-negative severe pneumocystis pneumonia.Serum markers in interstitial pneumonia with and without Pneumocystis jirovecii colonization: a prospective studyRisk Factors for the Mortality of Pneumocystis jirovecii Pneumonia in Non-HIV Patients Who Required Mechanical Ventilation: A Retrospective Case Series StudySerum antibody levels to the Pneumocystis jirovecii major surface glycoprotein in the diagnosis of P. jirovecii pneumonia in HIV+ patients.Clinical characteristics of Pneumocystis pneumonia in non-HIV patients and prognostic factors including microbiological genotypes.Pneumocystis pneumonia in HIV-infected and immunocompromised non-HIV infected patients: a retrospective study of two centers in China.Increased risk of refractory Mycoplasma pneumoniae pneumonia in children with atopic sensitization and asthma.Test performance of blood beta-glucan for Pneumocystis jirovecii pneumonia in patients with AIDS and respiratory symptomsClinical use of anti-TNF therapy and increased risk of infectionsPneumocystis pneumonia induced by treatment with low-dose tacrolimus and methylprednisolone in a patient with rheumatoid arthritis: a case reportMulticenter, prospective clinical evaluation of respiratory samples from subjects at risk for Pneumocystis jirovecii infection by use of a commercial real-time PCR assay.Serum (1->3)-beta-D-glucan levels in primary infection and pulmonary colonization with Pneumocystis jirovecii.Blood (1->3)-beta-D-glucan as a diagnostic test for HIV-related Pneumocystis jirovecii pneumonia.Diagnostic accuracy of serum 1,3-β-D-glucan for pneumocystis jiroveci pneumonia, invasive candidiasis, and invasive aspergillosis: systematic review and meta-analysis.Acute exacerbation of interstitial pneumonia associated with rheumatoid arthritis during the course of treatment for Pneumocystis jirovecii pneumonia: a case reportNon-HIV Pneumocystis pneumonia: do conventional community-acquired pneumonia guidelines under estimate its severity?Management of Pneumocystis jirovecii Pneumonia in Kidney Transplantation to Prevent Further Outbreak.Impact of HIV Infection Status on Interpretation of Quantitative PCR for Detection of Pneumocystis jirovecii.Diagnosis of pneumocystis pneumonia using serum (1-3)-β-D-Glucan: a bivariate meta-analysis and systematic review.S-1-induced lung injury combined with pneumocystis pneumoniaPlasma IL-6/IL-10 Ratio and IL-8, LDH, and HBDH Level Predict the Severity and the Risk of Death in AIDS Patients with Pneumocystis Pneumonia.Combined quantification of pulmonary Pneumocystis jirovecii DNA and serum (1->3)-β-D-glucan for differential diagnosis of pneumocystis pneumonia and Pneumocystis colonizationDrug-induced Pneumonitis Following the Administration of TAS-102.Update on the diagnosis and treatment of Pneumocystis pneumonia.Prognosis of pneumocystis pneumonia complicated in patients with rheumatoid arthritis (RA) and non-RA rheumatic diseases.Pneumocystis jirovecii pneumonia in kidney transplantation.Pneumocystis jirovecii pneumonia associated with etanercept treatment in patients with rheumatoid arthritis: a retrospective review of 15 cases and analysis of risk factors.Recent advances in the diagnosis of Pneumocystis jirovecii pneumonia in HIV-infected adults.Translational Development and Application of (1→3)-β-d-Glucan for Diagnosis and Therapeutic Monitoring of Invasive Mycoses.Serological diagnosis of pneumocystosis: production of a synthetic recombinant antigen for immunodetection of Pneumocystis jirovecii.(1-3)-beta-D-glucan in association with lactate dehydrogenase as biomarkers of Pneumocystis pneumonia (PcP) in HIV-infected patients.Pneumocystis jirovecii colonization in Chronic Obstructive Pulmonary Disease (COPD).Approach to Fungal Infections in Human Immunodeficiency Virus-Infected Individuals: Pneumocystis and Beyond.A Four-Center Retrospective Study of the Efficacy and Toxicity of Low-Dose Trimethoprim-Sulfamethoxazole for the Treatment of Pneumocystis Pneumonia in Patients without HIV Infection.PJP granuloma in an Immune competent host: Case report and literature review.
P2860
Q22241388-725AEA43-A4BB-40EE-9BCE-C6B03AFD76D9Q24614334-63ADD72C-610A-4A35-9467-ED26A082AC64Q26781920-82C18E50-A88B-4DC4-A3AE-179C978996CAQ26795592-E05B388D-8431-4E26-B1F7-26642F9F8819Q28552956-DEA288E2-14EA-4713-8FC4-3D72137421F3Q33389994-33442C32-BAEC-4522-9555-ED3FDAA0F6A2Q33433277-7DC74B6E-FA40-4393-89B6-D8D00B3D8055Q33711158-3A9B10F6-6C36-4B7A-9736-3CD5F413989CQ33769075-D520C61A-E82C-4D0B-8793-1FD373876191Q33856426-FBFE74C3-8DD5-4A48-8235-41FF955F99ABQ33910458-2C1996C4-4EE5-4ACA-80E3-B7D1FB830CAFQ33969439-5B7D3A4E-141C-44C4-9143-11775AFE49C3Q34273820-C6249341-ACBF-42CD-9B74-A3456E8DE5EDQ34338096-2D1DF9C3-947F-467B-842E-9266D97BAAEAQ34461860-0F8555D3-B4D2-4AF2-ADBD-5B5950BB1247Q35066605-629A14B6-FDF0-4CD6-ADDE-0D427118DB55Q35066665-B18B9BF1-7819-49B1-BAF2-8C33C59741EFQ35193330-23D6CED9-5970-414C-B1CE-717B46246653Q35668212-AAA78F7A-4A8A-4D88-B409-0182EDBA2148Q35998811-91F83FEA-2436-42E0-B9E9-66BFA4344200Q36151648-BA4220DE-E3CB-414E-ABBE-7F4B7BD603A4Q36288984-56EC03D1-514E-4C8D-9F72-650CB9D3B51DQ36297681-E8125959-4D1D-4E22-B2FC-7EABFD31B821Q36437449-BD6D257A-FA69-4FBE-918B-EB26FE5EC500Q36705272-55162709-243F-4F3E-8896-E21C4B071EF0Q37192459-E5207090-2152-4872-BB28-C06CF958A2D3Q37264267-E4F957B8-8221-46CA-A2B3-86AF4F0E3172Q37383193-5AEF9D74-6CF2-40B6-9960-E6B259916E9EQ37782191-BC5D5CF1-90A7-414C-A761-49359021AE2CQ37942495-36E033B4-F0F8-4B72-A064-5FB9B8F36A75Q37957313-A8A3C054-EBFD-4C16-881C-2ABBF4381A15Q37987077-E2883301-38BA-4EAD-B65C-5EE3FE6F8B71Q38093248-B793923E-685E-4062-B099-A6F399DDFD36Q38679742-5B3558AA-989B-47F5-BE98-18A0EB52DA76Q38797520-FB8A66BF-571C-4251-BD1A-188580BAFF0DQ38995769-30821E01-7C5D-40DD-A0E8-AD1D0C7899EAQ39417008-15B61BC6-E495-45FA-A0A9-514A7338EB63Q39575552-A46CA303-B62E-43CC-BF65-0FC2625DED84Q40046796-CD4CB87D-6B35-44BC-A495-A389C1987D06Q40073726-37A43E8C-20A3-4DB6-809F-96F974DE7602
P2860
Serum indicators for the diagnosis of pneumocystis pneumonia.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Serum indicators for the diagnosis of pneumocystis pneumonia.
@en
Serum indicators for the diagnosis of pneumocystis pneumonia.
@nl
type
label
Serum indicators for the diagnosis of pneumocystis pneumonia.
@en
Serum indicators for the diagnosis of pneumocystis pneumonia.
@nl
prefLabel
Serum indicators for the diagnosis of pneumocystis pneumonia.
@en
Serum indicators for the diagnosis of pneumocystis pneumonia.
@nl
P2093
P356
P1433
P1476
Serum indicators for the diagnosis of pneumocystis pneumonia.
@en
P2093
Akitoshi Ishizaka
Naoki Hasegawa
Sadatomo Tasaka
Seiki Kobayashi
Tomoyasu Nishimura
Tsutomu Takeuchi
Wakako Yamada
P304
P356
10.1378/CHEST.06-1467
P407
P577
2007-04-01T00:00:00Z